David V. Smith - Jun 8, 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for David V. Smith
Stock symbol
IOBT
Transactions as of
Jun 8, 2023
Transactions value $
$0
Form type
4
Date filed
6/13/2023, 07:54 PM
Previous filing
Jun 16, 2022
Next filing
Jun 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +41.5K $0.00 41.5K Jun 8, 2023 Common Stock 41.5K $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest on June 8, 2024, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.